Home › Funds › Sofinnova Investments, Inc. › EXEL

Sofinnova Investments, Inc. position in EXEL

EXELIXIS INC · Health Care

Sofinnova Investments, Inc. reported holding 254,200 shares of EXEL (EXELIXIS INC) in its Q2 2026 13F filing — a position valued at US$13.8M, representing 0.74% of its reported portfolio and ranking #33 among its reported holdings. Sofinnova Investments, Inc. has disclosed EXEL holdings in 3 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)254.20K sh
Reported value held$13.83M
Portfolio Weight0.74%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Sofinnova Investments, Inc.'s EXEL position evolved

Sofinnova Investments, Inc. first disclosed a stake in EXEL in Q3 2023 at 830,764 shares (US$18.2M). Across 3 filings, Sofinnova Investments, Inc. increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 254,200 shares valued at US$13.8M — an increase of 2,700 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 830.76K $18.15M New
Q1 2026 251.50K $10.79M New
Q2 2026 254.20K $13.83M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About EXEL and 13F data

EXEL (EXELIXIS INC) is a Health Care company. 42 other funds we track also report a position in EXEL — the largest reported positions include Farallon Capital Management (US$732.8M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$732.8M), Renaissance Technologies (US$730.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EXEL

All EXEL fund holders →

FAQ

How long has Sofinnova Investments, Inc. held EXEL?

Sofinnova Investments, Inc. has disclosed EXEL holdings in 3 of the last 12 reported quarters, going back to Q3 2023.

What is Sofinnova Investments, Inc.'s current position in EXEL?

As of Q2 2026, Sofinnova Investments, Inc. holds 254.20K shares of EXEL (EXELIXIS INC), valued at $13.83M, representing 0.74% of its reported portfolio and ranking #33.

Has Sofinnova Investments, Inc. been buying or selling EXEL?

In the latest 13F filing (Q2 2026), Sofinnova Investments, Inc. increased its position in EXEL.

Which other funds hold EXEL?

Other major institutional holders of EXEL include Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., Renaissance Technologies, among 42 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.